| Management target | Revenue 100.0% FY31 |
|---|
| Revenue growth | Revenue declined 5% YoY to ₹609Cr due to delayed monsoon. |
|---|---|
| Margins | Gross margins expanded to 31.6%; EBITDA margin contracted to 9.1%. |
| Demand visibility | Improving demand visibility following better August rains across the country. |
| Management confidence | Balanced; optimistic about Q2-Q4 recovery despite a difficult Q1. |
Growth
Revenue fell 5% YoY to ₹609Cr. Gross profit rose 4% with margins hitting 31.6% via premium products.
Outlook
Management aims to double sales in 4-5 years as capex cycle concludes.
Risks
High raw material volatility (solvents/plastics) and delayed monsoon dependency in Southern India.
Last quarter's promises, checked
Delivered
- Guided Q4 growth → delivered 19% YoY (= BEAT)
- Guided FY26 premium product growth → delivered 24% (= BEAT)
- Guided FY26 revenue growth → delivered 7% (= BEAT)
Partly delivered
- Guided working capital reduction → delivered 140-150 days (still elevated) (= PARTIAL)
Missed
- Guided volume growth → delivered 5% vs 13% decline in current Q1 (= MISS)
- Guided price hike absorption → delivered rollbacks in July (= MISS)
Earnings Call Transcript filed with BSE, NSE: INSECTICID. Summary written with AI assistance from the document.
Insecticides (India) Ltd: key numbers
- Share price
- ₹602.50
- Market cap
- ₹1,753 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 14.0×Sector 37.5×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Investor Presentation: Key Takeaways
IIL reported FY26 turnover of ₹2,140 Cr, focusing on premiumization via its 'Tractor Brand'. Strategy emphasizes innovative product launches and international collaborations to shift towards high-margin B2C segments.
Insecticides (India) Q1 FY27 Results: Net Profit ₹43.9 Cr, Down 24.4% YoY
Insecticides (India) Ltd reported revenue from operations of ₹611.5 Cr (-11.5% YoY) and net profit of ₹43.9 Cr (-24.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹43.9 Cr · -24.4% YoY
Insecticides (India) Earnings Call: Key Takeaways
IIL delivered FY26 revenue of ₹2,140cr (up 7%) with EBITDA of ₹227cr. Strategy focuses on premiumization via the Kaeros brand and R&D partnerships with Nissan and Corteva.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides India delivered steady 7% revenue growth in FY26, balancing raw material inflation through premiumization and strategic partnerships while preparing for a major brand expansion via its new subsidiary, Kairos.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides (India) reported FY26 turnover of ₹2,140 Cr. Company shifting toward premiumization with B2C premium product share rising from 51% (FY23) to 58% (FY26).